Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in BHST held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Alyeska Investment Group, L.P. | 757K | $3.3M | 0.0% | 4.369% | 0.01% |
| 2 | True North Advisors, LLC | 168K | $729K | +381.0% | 0.970% | 0.08% |
| 3 | Evercore Wealth Management, LLC | 139K | $605K | 0.0% | 0.805% | 0.01% |
| 4 | Magnus Financial Group LLC | 55K | $239K | 0.0% | 0.317% | 0.02% |
| 5 | KING LUTHER CAPITAL MANAGEMENT CORP | 40K | $174K | 0.0% | 0.231% | 0.00% |
| 6 | XTX Topco Ltd | 30K | $129K | -10.9% | 0.171% | 0.00% |
| 7 | Silverberg Bernstein Capital Management LLC | 26K | $113K | — | 0.151% | 0.06% |
| 8 | TD Waterhouse Canada Inc. | 24K | $102K | +97.9% | 0.137% | 0.00% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16K | $71K | +11.2% | 0.095% | 0.00% |
| 10 | CITADEL ADVISORS LLC | 15K | $64K | -4.0% | 0.085% | 0.00% |
| 11 | JANE STREET GROUP, LLC | 13K | $57K | -53.3% | 0.075% | 0.00% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 12K | $51K | 0.0% | 0.068% | 0.00% |
| 13 | Vident Advisory, LLC | 12K | $50K | — | 0.067% | 0.00% |
| 14 | MORGAN STANLEY | 3K | $14K | 0.0% | 0.019% | 0.00% |
| 15 | ROYAL BANK OF CANADA | 3K | $13K | 0.0% | 0.017% | 0.00% |
| 16 | UBS Group AG | 629 | $3K | -46.4% | 0.004% | 0.00% |
| 17 | ADVISOR GROUP HOLDINGS, INC. | 628 | $3K | -98.2% | 0.004% | 0.00% |
| 18 | THOMPSON SIEGEL & WALMSLEY LLC | 387K | $2K | +3.2% | 2.232% | 0.03% |
| 19 | NATIONAL BANK OF CANADA /FI/ | 154 | $657 | 0.0% | 0.001% | 0.00% |
| 20 | Federation des caisses Desjardins du Quebec | 76 | $325 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in BHST — a direct measure of their conviction.
Filings activity in BHST during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new BHST position in Q1 2026
Institutions that fully closed their BHST position in Q1 2026
6 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 20 | 9.1% | 10.29% | 1.25 pp | $6M | 11% |
| Q4 2025 | 22 | +144% | 11.54% | +7.14 pp | $6M | +162% |
| Q3 2025 | 9 | +0.0% | 4.40% | +3.09 pp | $2M | +237% |
| Q2 2025 | 9 | +0.0% | 1.31% | 0.14 pp | $1M | 9.7% |
| Q1 2025 | 9 | +50% | 1.45% | +0.47 pp | $1M | +48% |
| Q4 2024 | 6 | — | 0.98% | — | $1M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BHST stock.
Based on Q1 2026 13F filings, institutional ownership of BioHarvest Sciences Inc. Common Stock stands at 10.3%, held across 20 reporting institutions.
Alyeska Investment Group, L.P. is the largest reported institutional holder of BHST, with approximately 757,064 shares worth $0.00B as of Q1 2026.
Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of BHST, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC.
Our composite Smart Money Score for BHST is 42 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
2 institutions opened new positions in BHST during Q1 2026, while 4 fully exited. 2 added to existing positions and 16 trimmed.
BHST institutional ownership fell by 1.25 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 96.6% of all reported 13F value in BHST, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
BioHarvest Sciences Inc. Common Stock (BHST) Institutional Ownership